Rivastigmine

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2543 publications

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study.

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study.

Journal: BMJ open

Published: June 15, 2026

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Journal: Innovations in pharmacy

Published: June 08, 2026

The Effect of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists on the Risk of Development and Progression of Age-Related Macular Degeneration.

The Effect of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists on the Risk of Development and Progression of Age-Related Macular Degeneration.

Journal: Journal of vitreoretinal diseases

Published: June 01, 2026

Advances in Anti-Dementia Therapies in Older Adults

Advances in Anti-Dementia Therapies in Older Adults

Journal: Deutsche medizinische Wochenschrift (1946)

Published: May 29, 2026

Novel resveratrol-inspired thieno-benzimidazoles and thieno-oxazoles - Synthesis, selective butyrylcholinesterase inhibition and molecular modeling.

Novel resveratrol-inspired thieno-benzimidazoles and thieno-oxazoles - Synthesis, selective butyrylcholinesterase inhibition and molecular modeling.

Journal: Bioorganic chemistry

Published: April 13, 2026

Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: April 13, 2026

Computational toxicity profiling of the UV stabilizer UV-328 against the human brain enzyme acetylcholinesterase.

Computational toxicity profiling of the UV stabilizer UV-328 against the human brain enzyme acetylcholinesterase.

Journal: International journal of environmental health research

Published: April 13, 2026

Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: April 13, 2026

Cholinesterase Inhibitory Activity of Alkylated Quinobenzothiazinium Salts.

Cholinesterase Inhibitory Activity of Alkylated Quinobenzothiazinium Salts.

Journal: Molecules (Basel, Switzerland)

Published: April 01, 2026

Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study.

Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study.

Journal: Journal of managed care & specialty pharmacy

Published: March 26, 2026

Drugs for dementia.

Drugs for dementia.

Journal: The Medical letter on drugs and therapeutics

Published: March 24, 2026

Comparison table: Drugs for Alzheimer's disease dementia.

Comparison table: Drugs for Alzheimer's disease dementia.

Journal: The Medical letter on drugs and therapeutics

Published: March 24, 2026

Showing 1-12 of 2,543

Last Updated: 06/30/2026